Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
about
Recent advances in understanding hepatic drug transportComparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview.Reappraisal and perspectives of clinical drug-drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus.
P2860
Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@en
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@nl
type
label
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@en
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@nl
prefLabel
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@en
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@nl
P2860
P356
P1476
Transporter-Enzyme Interplay: ...... nd Dynamic Mechanistic Models.
@en
P2093
Ayman F El-Kattan
Manthena V Varma
P2860
P304
P356
10.1002/JCPH.695
P478
56 Suppl 7
P577
2016-07-01T00:00:00Z